What are Opioids, really?
Opioids are the oldest painkillers we have. People were scraping resin from the opium poppy thousands of years before anyone knew what a receptor was. But the genuinely strange discovery came in the 1970s, when researchers found that the human brain is studded with receptors shaped precisely to fit opium's active molecules. Which raises an obvious question: why would evolution build a lock for a Turkish poppy?
It didn't. It built the lock for our own keys. Your body makes its own opioids — endorphins, enkephalins, dynorphins — an internal pain-suppression hotline that picks up during hard exercise, after injury, under acute stress, during childbirth, even during social bonding. It is why a soldier can walk off a serious wound and only notice it later. Opioid drugs are foreign keys that fit the same lock, except they turn it harder and longer than anything your body would ever release on its own.
The modern family: morphine (Zomorph), oxycodone (OxyContin), hydrocodone (the opioid half of Vicodin), hydromorphone (Palladone), codeine, tramadol, fentanyl (the Duragesic patch), buprenorphine (the Transtec patch, and Suboxone with naloxone). And naloxone (Narcan) alone, which does the opposite — it jams the lock so nothing can turn it. There are three main receptor types, μ (mu), κ (kappa) and δ (delta), and almost every opioid you would actually be prescribed works mainly on μ. Everything wonderful about this class and everything terrible about it comes through that one receptor.
How they work — the simple version
Think of pain as an alarm system wired through your body. Nerve endings are the smoke detectors, the spinal cord is the cabling, the brain is the control room where the siren sounds. NSAIDs work down at the detectors, making them less twitchy. Opioids skip all that and walk straight into the control room to cut power to the alarm panel. The fire is still burning. Nobody is being told about it.
Mechanically: μ-receptors sit on neurons in the dorsal horn of the spinal cord, the brainstem and the limbic system. They are G-protein coupled receptors of the Gi/o type — a technical way of saying that when something docks into them, they turn things down. Levels of a messenger molecule called cAMP fall inside the cell. Potassium channels swing open and let positive charge leak out. Calcium channels close. The result is a neuron whose inside has gone more negative — hyperpolarised — and a hyperpolarised neuron is one you have to shout at to make it fire. On the sending side of the synapse, less calcium means less neurotransmitter released at all. The message arrives and simply doesn't get relayed (Stein, Annual Review of Medicine, 2016).
At the same time, opioids switch on the descending inhibitory pathways — a circuit running from a midbrain region called the periaqueductal grey down through the raphe nuclei, flooding the spinal cord with serotonin and noradrenaline that suppress incoming pain traffic. So it's a pincer movement: the signal is muffled where it enters, and pushed back down from the top.
And opioids don't just reduce how strong pain feels — they change how much you mind it. People on morphine often say the pain is still there, it just isn't bothering them. That's the limbic component, and inconveniently it's also what makes this class habit-forming.
Not every opioid plays the same game:
- Buprenorphine is a partial agonist — it only turns the key part of the way. Push it and pain relief keeps climbing, but respiratory depression flattens against a ceiling it can't easily cross (Dahan et al., British Journal of Anaesthesia, 2006). That ceiling is why buprenorphine became a backbone of treatment for opioid use disorder.
- Tramadol is two drugs in one trench coat: a weak μ-agonist (with a considerably stronger metabolite) plus a serotonin–noradrenaline reuptake inhibitor. That second job is not a footnote — it drives most of tramadol's interaction problems.
- Codeine is a prodrug. It does close to nothing until a liver enzyme called CYP2D6 converts it into morphine, and how fast you do that is written into your genes. Some people barely convert it and wonder why codeine "doesn't work". Others convert far too fast — a story we come back to below.
- Fentanyl is intensely fat-soluble, so it reaches the brain very fast, and it is potent by orders of magnitude relative to morphine — superb in an operating theatre, catastrophic in an unregulated street supply.
What else they do to your body, beyond pain relief
μ-receptors are not politely confined to pain pathways. They sit in the wall of your intestine, the breathing centres of the brainstem, the reward circuitry, the muscle that controls your pupil. So the side-effect list isn't a set of unrelated hazards — it's the same drug doing the same thing in different rooms of the house.
The gut. Opioid receptors in the bowel wall slow peristalsis to a crawl. The result is constipation — and here is the part that surprises people: this is the one opioid effect tolerance almost never develops to. Nausea fades, drowsiness fades, this doesn't. It is a management problem for the whole length of treatment, not a rough first week. Ordinary laxatives often aren't enough, which is why a purpose-built class exists: peripherally acting μ-opioid receptor antagonists — methylnaltrexone, naloxegol, naldemedine. They block gut receptors but barely cross into the brain, so the bowel wakes up while pain relief stays intact (Nee et al., Clinical Gastroenterology and Hepatology, 2018).
Nausea and vomiting. A patch of brainstem called the chemoreceptor trigger zone sits deliberately outside the blood–brain barrier, sampling for poisons. Opioids set it off. This one usually settles over the first days.
Breathing. This is the effect that kills. Normally, rising carbon dioxide in your blood makes you breathe harder without you thinking about it. Opioids blunt that reflex. In an overdose the person isn't thrashing or gasping — breathing simply gets slower and shallower until it stops. It is quiet, which is why people in the next room miss it. Tolerance to pain relief and to respiratory depression build roughly in parallel, so a long-term patient on a stable regimen is at lower risk than someone opioid-naive. It's also why the deadliest moment in an opioid career is the return after a gap — detox, hospital, prison. Tolerance is gone. The old habit isn't.
Reward. μ-receptors in the limbic system release the brakes on dopamine in the nucleus accumbens. Some describe warmth and euphoria; plenty of others just feel sick and heavy-lidded. But that dopamine surge is the biological reason this class carries misuse liability at all (Volkow & McLellan, NEJM, 2016).
Physical dependence. Days to weeks of continuous use is enough for the body to recalibrate around the drug. Stop abruptly and you get withdrawal: sweating, gooseflesh, aching joints, diarrhoea, insomnia, restlessness, crawling anxiety. It is genuinely awful. It is also — unlike withdrawal from alcohol or benzodiazepines — not typically life-threatening in an otherwise healthy adult. Worth stating plainly, because fear of withdrawal keeps a lot of people using who would rather stop.
Pupils. Pinpoint, and they stay pinpoint even in a dark room. Together with unresponsiveness and slow breathing, that's the classic opioid toxidrome. Less discussed but real: itching, urinary retention, low blood pressure, and with long use, suppressed sex hormones.
What people usually take with them, and why
The organising principle of modern pain management is multimodal analgesia: don't ask one drug to do everything. The WHO analgesic ladder, published in 1986 and carried into the 2018 WHO cancer pain guideline, still shapes practice — a non-opioid foundation of paracetamol or an NSAID, with an opioid layered on top when the pain outgrows it. The point is the opioid-sparing effect: the same relief on less opioid means fewer side effects. That's why fixed combinations exist at all — hydrocodone with acetaminophen in Vicodin, codeine with paracetamol in countless products.
Two catches. An NSAID brings its own stomach, kidney and cardiovascular baggage. And the paracetamol hidden inside combination products is a trap — people take a separate paracetamol on top, never counting what they already had.
Tramadol and antidepressants. Because tramadol also blocks serotonin reuptake, stacking it with SSRIs, SNRIs, MAOIs, triptans or linezolid raises the risk of serotonin syndrome, and it lowers the seizure threshold on its own (Beakley et al., Pain Physician, 2015). It is the interaction most often missed, because both drugs look routine on a list.
Buprenorphine with naloxone (Suboxone). Naloxone is barely absorbed when the film dissolves under the tongue, so taken as directed it's an inert passenger. Crush and inject it and the naloxone becomes fully active, immediately precipitating withdrawal. The deterrent is built into the chemistry rather than the label.
Naloxone on its own (Narcan). A pure competitive antagonist — it shoves the opioid off the receptor, and breathing restarts within minutes. Nasal-spray kits are now distributed to the public in many countries. One caveat matters enormously: naloxone's half-life is roughly 60 to 90 minutes — shorter than many opioids, and far shorter than long-acting formulations, methadone or fentanyl analogues. The person can wake up, look fine, and then go back down as it wears off. It is a call-the-ambulance drug, never an instead-of-the-ambulance drug.
And then the combination that does most of the killing: opioids plus benzodiazepines — or alcohol, gabapentinoids, z-drugs, or any other central nervous system depressant. Each suppresses breathing by its own route, and together the effect is more than additive. The FDA required boxed warnings on both classes for exactly this reason in 2016, and a large retrospective analysis in the BMJ found that patients prescribed both concurrently had substantially higher overdose risk than those on an opioid alone (Sun et al., 2017). If you retain one sentence from this article, make it that one.
A note for travellers. Almost all opioids are controlled internationally under the UN drug conventions, and personal-use exemptions vary wildly by country. Practical minimum: keep the medicine in its original labelled packaging, carry the prescription and a doctor's letter in English, and check the destination's rules before you fly, not at the border. Japan requires an advance import certificate (yakkan shoumei); the UAE operates close to zero tolerance and has detained travellers carrying legitimately prescribed drugs; tramadol is tightly controlled in Egypt and Saudi Arabia while being an ordinary prescription drug across much of Europe. The International Narcotics Control Board maintains a country-by-country guide — the right first stop, and one that changes.
Red flags — when to call a doctor
Signs of overdose. Call emergency services immediately, give naloxone if you have it, and do not wait to see whether things improve.
- The person can't be woken — not drowsy, genuinely unrousable
- Breathing that is slow, shallow, gurgling, snoring-like, or has stopped
- Lips, fingertips or face turning blue or grey
- Pinpoint pupils that don't widen in a dark room
- Limp body, cold and clammy skin
If you aren't sure it's an opioid, give the naloxone anyway. If opioids aren't involved, it does essentially nothing — there is no version of this where withholding it is the safer bet.
Serotonin syndrome, most often when tramadol meets a serotonergic antidepressant: tremor, twitching muscles, agitation or confusion, fever, heavy sweating, a racing heart, and — unusually for anything opioid-related — dilated rather than pinpoint pupils. This is an emergency.
Stopping abruptly after prolonged use. Withdrawal won't usually kill a healthy adult, but it is severe enough that people give up and return to the drug — and the return is where the danger is. Plan a taper with a prescriber, and never restart at the amount you were on before a break. That is the classic fatal mistake.
Escalating use. Needing more for the same effect, taking it for reasons other than pain, running out early, feeling unable to stop even when you want to. This is not a character flaw, it is a diagnosable and treatable medical condition. The conversation to have is with a prescriber, and earlier is better than later.
What people get wrong
"Take opioids and you'll get addicted." Dependence and addiction are not the same thing. Dependence is pharmacology — the body adapting, which happens to nearly everyone on continuous treatment. Addiction, properly called opioid use disorder, is a behavioural condition defined by compulsion and loss of control. Most patients treated appropriately never develop it, though the risk isn't zero and isn't spread evenly across people (Volkow & McLellan, 2016). The error runs both ways: the 1990s underestimated the risk and produced a catastrophe, and the overcorrection since has left plenty of cancer and post-surgical patients in unnecessary pain.
"Morphine hastens death in palliative care." Persistent, cruel, and families act on it. The Cochrane overview of opioids for cancer pain found no evidence that properly titrated opioids shorten life — while uncontrolled pain, and the exhaustion that comes with it, are themselves harmful (Wiffen et al., Cochrane Database of Systematic Reviews, 2017). Refusing morphine for a dying relative doesn't buy time. It buys suffering.
"Heroin is a fundamentally different drug from prescription opioids." It isn't. Heroin is diacetylmorphine, a prodrug that crosses into the brain faster and then converts to morphine. Same receptor, same mechanism. What differs is legal status, route, and above all that the illicit supply is unlabelled — fentanyl analogues contaminating it are the main reason overdose death curves look the way they do (Compton, Jones & Baldwin, NEJM, 2016).
"Codeine is the gentle one, so it's fine for children." Codeine is a genetic lottery ticket. Ultra-rapid CYP2D6 metabolisers convert far too much of it into morphine, far too fast — and children died after tonsillectomy because of it. In 2017 the FDA contraindicated both codeine and tramadol in children under 12 and restricted their use in adolescents and breastfeeding mothers; the EMA had already moved the same way. "Weak opioid" is not a synonym for "safe opioid".
"Needing more means I'm becoming addicted." Tolerance is a normal receptor-level adaptation and tells you nothing about addiction on its own. It's information, not a verdict. Worsening pain can also mean the underlying disease has progressed — worth investigating rather than assuming.
"Tramadol isn't a real opioid." It absolutely is — a controlled substance in the United States since 2014 and in most other jurisdictions, with real misuse potential. On top of the ordinary opioid risks it adds serotonergic effects and a lowered seizure threshold that classic opioids don't carry.
Opioids are among the most valuable medicines ever discovered. There is no substitute for them in severe acute pain, in surgery, or at the end of life, and the reflex to treat every prescription as a moral hazard has its own body count. The right posture isn't fear. It's respect: know what the switch does, know what else it turns off on the way, and never flip it in the same room as a sedative.